Skip to main content
. 2017 Sep 15;8(50):87582–87597. doi: 10.18632/oncotarget.20908

Figure 3. Antimicrobial activity of myxinidin2 and myxinidin3 in gelatin.

Figure 3

(A) Cytotoxicity of 0% to 1% gelatin against normal human keratinocytes. (B) Sustained antimicrobial effect at each gelatin concentration was verified by determining the MIC. (C) and (D) Disc assays showing the antibacterial effects of myxinidin2 and myxinidin3 in 0.1% gelatin. Each experiment was performed in triplicate, with at least three independent experiments.